|
524412 AAREYDRUGS Group (T) 19 May,15:13
85.20
-3.25 (-3.67%)
HOW HOT IS THIS STOCK?
Last 15 days data © Rediff.com Add to Watchlist 
|
BSE | NSE
 ZoomRefreshDay
Wk
Mn
6Mn
Yr
|
1 min read
17 minutes ago
2 min read
46 minutes ago
2 min read
46 minutes ago
1 min read
54 minutes ago
| Mar ' 25 | Mar ' 24 | Mar ' 23 | Mar ' 22 | Mar ' 21 | |
|---|---|---|---|---|---|
| Sales | 473.94 | 395.62 | 414.25 | 492.68 | 348.42 |
| Operating profit | 2.25 | 4.45 | 3.02 | 11.27 | 4.64 |
| Interest | 4.02 | 4.38 | 2.87 | 2.00 | 2.43 |
| Gross profit | 8.05 | 7.04 | 7.59 | 12.02 | 9.22 |
| EPS (Rs) | 1.43 | 1.67 | 1.49 | 2.58 | 2.79 |
1 min read
10 minutes ago
1 min read
14 minutes ago
Q: What is the current share price of Aarey Drugs & Pharmaceuticals Ltd.?
A: The current share price of Aarey Drugs & Pharmaceuticals Ltd. is ₹ 85.20 (for BSE as on 19 May,15:13). The 52-week range is ₹ 100.00 - 49.01. Prices are updated based on live market data.
Q: What is the market capitalization of Aarey Drugs & Pharmaceuticals Ltd.?
A: Aarey Drugs & Pharmaceuticals Ltd. has a market capitalization of ₹ 241.97 Cr, making it a company.
Q: What is the PE ratio of Aarey Drugs & Pharmaceuticals Ltd.?
A: The Price-to-Earnings (PE) ratio of Aarey Drugs & Pharmaceuticals Ltd. is 61.67, indicating its valuation relative to earnings.
Q: Is Aarey Drugs & Pharmaceuticals Ltd. a good investment?
A: Aarey Drugs & Pharmaceuticals Ltd. is considered based on its financial performance, sector outlook, and market conditions. Investors should evaluate fundamentals and consult financial advisors before investing.
Q: Does Aarey Drugs & Pharmaceuticals Ltd. pay dividends?
A: Yes. Aarey Drugs & Pharmaceuticals Ltd. pay dividends. The latest dividend yield is 1%.
Q: What are the latest financial results of Aarey Drugs & Pharmaceuticals Ltd.?
A: Aarey Drugs & Pharmaceuticals Ltd. has reported its latest annual results with revenue of ₹ 473.94 and net profit/loss of ₹ 4.02.
© 2026 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
